Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 14

1.

Neutralization of HIV subtypes A and D by breast milk IgG from women with HIV infection in Uganda.

Palaia JM, McConnell M, Achenbach JE, Gustafson CE, Stoermer KA, Nolan M, Guay LA, Leitner TK, Matovu F, Taylor AW, Fowler MG, Janoff EN.

J Infect. 2014 Mar;68(3):264-72. doi: 10.1016/j.jinf.2013.11.002. Epub 2013 Nov 13.

PMID:
24239588
2.

Kinetics of nevirapine and its impact on HIV-1 RNA levels in maternal plasma and breast milk over time after perinatal single-dose nevirapine.

Aizire J, McConnell MS, Mudiope P, Mubiru M, Matovu F, Parsons TL, Elbireer A, Nolan M, Janoff EN, Fowler MG.

J Acquir Immune Defic Syndr. 2012 Aug 15;60(5):483-8. doi: 10.1097/QAI.0b013e318246bf9e.

PMID:
22217678
3.

Emergence and persistence of nevirapine resistance in breast milk after single-dose nevirapine administration.

Hudelson SE, McConnell MS, Bagenda D, Piwowar-Manning E, Parsons TL, Nolan ML, Bakaki PM, Thigpen MC, Mubiru M, Fowler MG, Eshleman SH.

AIDS. 2010 Feb 20;24(4):557-61. doi: 10.1097/QAD.0b013e3283346e60.

4.

Sustainability science: an integrated approach for health-programme planning.

Gruen RL, Elliott JH, Nolan ML, Lawton PD, Parkhill A, McLaren CJ, Lavis JN.

Lancet. 2008 Nov 1;372(9649):1579-89. doi: 10.1016/S0140-6736(08)61659-1. Review.

PMID:
18984192
5.

Virologic and immunologic response to antiretroviral therapy and predictors of HIV type 1 drug resistance in children receiving treatment in Abidjan, Côte d'Ivoire.

Adjé-Touré C, Hanson DL, Talla-Nzussouo N, Borget MY, Kouadio LY, Tossou O, Fassinou P, Bissagnene E, Kadio A, Nolan ML, Nkengasong JN.

AIDS Res Hum Retroviruses. 2008 Jul;24(7):911-7. doi: 10.1089/aid.2007.0264.

PMID:
18593341
6.

Impact of genotypic drug resistance mutations on clinical and immunological outcomes in HIV-infected adults on HAART in West Africa.

Seyler C, Adjé-Touré C, Messou E, Dakoury-Dogbo N, Rouet F, Gabillard D, Nolan M, Toure S, Anglaret X.

AIDS. 2007 May 31;21(9):1157-64.

7.

Poliovirus vaccine shedding among persons with HIV in Abidjan, Cote d'Ivoire.

Hennessey KA, Lago H, Diomande F, Akoua-Koffi C, Caceres VM, Pallansch MA, Kew OM, Nolan M, Zuber PL.

J Infect Dis. 2005 Dec 15;192(12):2124-8. Epub 2005 Nov 8.

PMID:
16288377
8.

Presence of CRF09_cpx and complex CRF02_AG/CRF09_cpx recombinant HIV type 1 strains in Côte d'Ivoire, West Africa.

Toni T, Adjé-Touré C, Vidal N, Minga A, Huet C, Borger MY, Recordon-Pinson P, Masquelier B, Nolan M, Nkengasong J, Fleury HJ, Delaporte E, Peeters M.

AIDS Res Hum Retroviruses. 2005 Jul;21(7):667-72.

PMID:
16060839
9.

HIV-specific T helper responses and frequency of exposure among HIV-exposed seronegative female sex workers in Abidjan, Cote d'Ivoire.

Jennes W, Vuylsteke B, Borget MY, Traore-Ettiegne V, Maurice C, Nolan M, Nkengasong JN, Kestens L.

J Infect Dis. 2004 Feb 15;189(4):602-10. Epub 2004 Jan 29.

PMID:
14767812
10.

The most efficient use of resources to identify those in need of antiretroviral treatment in Africa: empirical data from Côte d'Ivoire's Drug Access Initiative.

Diomandé FV, Bissagnéné E, Nkengasong JN, Maurice C, Monga B, Laga M, Nolan ML.

AIDS. 2003 Jul;17 Suppl 3:S87-93.

PMID:
14565614
11.

Antiretroviral therapy in HIV-2-infected patients: changes in plasma viral load, CD4+ cell counts, and drug resistance profiles of patients treated in Abidjan, Côte d'Ivoire.

Adjé-Touré CA, Cheingsong R, Garcìa-Lerma JG, Eholié S, Borget MY, Bouchez JM, Otten RA, Maurice C, Sassan-Morokro M, Ekpini RE, Nolan M, Chorba T, Heneine W, Nkengasong JN.

AIDS. 2003 Jul;17 Suppl 3:S49-54.

PMID:
14565609
12.

Polymorphism in protease and reverse transcriptase and phenotypic drug resistance of HIV-1 recombinant CRF02_AG isolates from patients with no prior use of antiretroviral drugs in Abidjan, Côte d'Ivoire.

Adjé-Touré C, Bilé CE, Borget MY, Hertog K, Maurice C, Nolan ML, Nkengasong JN.

J Acquir Immune Defic Syndr. 2003 Sep 1;34(1):111-3. No abstract available.

PMID:
14501802
13.

A review of clinical trials to prevent mother-to-child HIV-1 transmission in Africa and inform rational intervention strategies.

Nolan ML, Greenberg AE, Fowler MG.

AIDS. 2002 Oct 18;16(15):1991-9. Review. No abstract available.

PMID:
12370497
14.

Antiretroviral prophylaxis of perinatal HIV-1 transmission and the potential impact of antiretroviral resistance.

Nolan M, Fowler MG, Mofenson LM.

J Acquir Immune Defic Syndr. 2002 Jun 1;30(2):216-29. Review.

PMID:
12045685

Supplemental Content

Loading ...
Support Center